AU3747000A - 49 human secreted proteins - Google Patents

49 human secreted proteins

Info

Publication number
AU3747000A
AU3747000A AU37470/00A AU3747000A AU3747000A AU 3747000 A AU3747000 A AU 3747000A AU 37470/00 A AU37470/00 A AU 37470/00A AU 3747000 A AU3747000 A AU 3747000A AU 3747000 A AU3747000 A AU 3747000A
Authority
AU
Australia
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37470/00A
Inventor
George Komatsoulis
Craig A Rosen
Steven M. Ruben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU3747000A publication Critical patent/AU3747000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU37470/00A 1999-03-23 2000-03-16 49 human secreted proteins Abandoned AU3747000A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12605199P 1999-03-23 1999-03-23
US60126051 1999-03-23
US16990699P 1999-12-10 1999-12-10
US60169906 1999-12-10
PCT/US2000/006765 WO2000056753A1 (en) 1999-03-23 2000-03-16 49 human secreted proteins

Publications (1)

Publication Number Publication Date
AU3747000A true AU3747000A (en) 2000-10-09

Family

ID=26824224

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37470/00A Abandoned AU3747000A (en) 1999-03-23 2000-03-16 49 human secreted proteins

Country Status (5)

Country Link
EP (1) EP1165590A4 (en)
JP (1) JP2002539776A (en)
AU (1) AU3747000A (en)
CA (1) CA2368916A1 (en)
WO (1) WO2000056753A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101291683B (en) 2004-11-24 2011-08-17 纽普罗研究有限公司 Methods and compositions for treating conditions
EP2448960A1 (en) * 2009-06-30 2012-05-09 Abbott Laboratories Markers of xmrv infection and uses thereof
WO2021016330A2 (en) * 2019-07-22 2021-01-28 Oneskin, Inc. Polypeptides having anti-senescent effects and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998054963A2 (en) * 1997-06-06 1998-12-10 Human Genome Sciences, Inc. 207 human secreted proteins

Also Published As

Publication number Publication date
EP1165590A1 (en) 2002-01-02
CA2368916A1 (en) 2000-09-28
JP2002539776A (en) 2002-11-26
WO2000056753A1 (en) 2000-09-28
EP1165590A4 (en) 2003-02-26

Similar Documents

Publication Publication Date Title
AU1473501A (en) 21 human secreted proteins
AU1438001A (en) 27 human secreted proteins
AU1604401A (en) 18 human secreted proteins
AU1448701A (en) 15 human secreted proteins
AU3769700A (en) 45 human secreted proteins
AU2757500A (en) 33 human secreted proteins
AU1918601A (en) 23 human secreted proteins
AU3517000A (en) 50 human secreted proteins
AU3628600A (en) 46 human secreted proteins
AU1916101A (en) 19 human secreted proteins
AU1342501A (en) 32 human secreted proteins
AU3765500A (en) 50 human secreted proteins
AU3396600A (en) 49 human secreted proteins
AU3208700A (en) 33 human secreted proteins
AU3249300A (en) 47 human secreted proteins
AU1449001A (en) 28 human secreted proteins
AU1472801A (en) 24 human secreted proteins
AU3628700A (en) 49 human secreted proteins
AU3767300A (en) 47 human secreted proteins
AU3766800A (en) 48 human secreted proteins
AU3871300A (en) 50 human secreted proteins
AU4072300A (en) 50 human secreted proteins
AU3747000A (en) 49 human secreted proteins
AU1438201A (en) 25 human secreted proteins
AU3730500A (en) 50 human secreted proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase